DREAM is pleased to welcome Payam Peymani (PharmD, PhD) to the DREAM theme!
Dr. Peymani is a pharmacoepidemiologist whose research focuses on medication use during pregnancy and early life, maternal and child health outcomes, and emerging treatments for obesity and type 2 diabetes, including newer glucose-lowering and weight-management therapies.
Click here to learn more about Dr. Peymani.
Welcome to the DREAM theme!
What's New
All Articles
Dr. Payam Peymani Joins the DREAM Theme!
DREAM is pleased to welcome Payam Peymani (PharmD, PhD) to the DREAM theme! Dr. Peymani is a pharmacoepidemiologist whose research…
New iCARE research highlights kidney health in youth with type 2 diabetes
A new study from the iCARE cohort examined kidney health over two years in 188 youth living with type 2…
Canadian Lipid and Vascular Summit 2026
DREAM co-lead Dr. Vern Dolinsky and PhD student Khushali Trivedi attended the Canadian Lipid and Vascular Summit last week in…
15th Annual DREAM Symposium and DREAM Trainee Day
The DREAM theme is excited to announce the 2026 DREAM Diabetes Research Symposium: New Perspectives in Diabetes will be held…
Now Recruiting Participants for a Research Study!
The Type 1 Diabetes Exercise and Mentorship (TEAM) Trial is recruiting teenagers living with type 1 diabetes in the Winnipeg…
3 DREAM Researchers Receive Funding from 2026 CHRIM Operating Grants
Congratulations to Drs. Ayesha Saleem, Sukhpreet Tamana, and Jennifer Yamamoto who received close to $150,000 in funding from the 2026…